Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer

被引:84
作者
Viennois, Emilie [1 ,2 ]
Xiao, Bo [1 ]
Ayyadurai, Saravanan [1 ]
Wang, Lixin [1 ,2 ]
Wang, Peng G. [3 ,4 ]
Zhang, Quan [4 ]
Chen, Yue [4 ]
Merlin, Didier [1 ,2 ]
机构
[1] Georgia State Univ, Ctr Diagnost & Therapeut, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA
[2] Vet Affairs Med Ctr, Decatur, GA 30033 USA
[3] Georgia State Univ, Ctr Diagnost & Therapeut, Dept Chem, Atlanta, GA 30303 USA
[4] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China
基金
中国国家自然科学基金; 美国国家卫生研究院;
关键词
NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; BOWEL-DISEASE; 5-AMINOSALICYLIC ACID; INDUCED APOPTOSIS; CROHNS-DISEASE; PARTHENOLIDE; INFLIXIMAB; CHITOSAN; COLON;
D O I
10.1038/labinvest.2014.89
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the gastrointestinal (GI) tract associated with an increased risk of colorectal cancer (CRC). Current treatments for both IBD and colitis-associated CRC suffer from numerous side effects. Parthenolide (PTL) is a sesquiterpene lactone with anti-inflammatory activity, and previous studies have demonstrated that PTL is a potent inhibitor of the NF-kappa B pathway. Micheliolide (MCL), substantially more stable than PTL in vivo, was recently developed, and this study aimed to decipher its suitability as therapeutic tool for IBD and IBD-associated diseases. Similar to PTL, MCL inhibited NF-kappa B activation and subsequent pro-inflammatory pathways activation in vitro. Pro-drug forms of both compounds inhibited the DSS-induced colitis when administrated intraperitoneally or encapsulated in a polysaccharide gel designed to release drugs in the colon. Interestingly, MCL was found to attenuate carcinogenesis in AOM/DSS-induced CRC, thus providing new candidate for the treatment of inflammatory bowel disease and CRC.
引用
收藏
页码:950 / 965
页数:16
相关论文
共 53 条
[1]   Crosslinked chitosan implants as potential degradable devices for brachytherapy: In vitro and in vivo analysis [J].
Azab, AK ;
Orkin, B ;
Doviner, V ;
Nissan, A ;
Klein, M ;
Srebnik, M ;
Rubinstein, A .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (03) :281-289
[2]   Cancer in Crohn's Disease Patients Treated with Infliximab: A Long-term Multicenter Matched Pair Study [J].
Biancone, Livia ;
Petruzziello, Carmelina ;
Orlando, Ambrogio ;
Kohn, Anna ;
Ardizzone, Sandro ;
Daperno, Marco ;
Angelucci, Erika ;
Castiglione, Fabiana ;
D'Inca, Renata ;
Zotzi, Francesca ;
Papi, Claudio ;
Meucci, Gianmichele ;
Riegler, Gabriele ;
Sica, Giuseppe ;
Rizzello, Fernando ;
Mocciaro, Filippo ;
Onali, Sara ;
Calabrese, Emma ;
Cottone, Mario ;
Pallone, Francesco .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (03) :758-766
[3]   HYALURONAN AND WOUND-HEALING - A NEW PERSPECTIVE [J].
BURD, DAR ;
GRECO, RM ;
REGAUER, S ;
LONGAKER, MT ;
SIEBERT, JW ;
GARG, HG .
BRITISH JOURNAL OF PLASTIC SURGERY, 1991, 44 (08) :579-584
[4]   ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers [J].
Charrier, L ;
Yan, YT ;
Driss, A ;
Laboisse, CL ;
Sitaraman, SV ;
Merlin, D .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 288 (02) :G346-G353
[5]   Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation [J].
Chassaing, Benoit ;
Srinivasan, Gayathri ;
Delgado, Maria A. ;
Young, Andrew N. ;
Gewirtz, Andrew T. ;
Vijay-Kumar, Matam .
PLOS ONE, 2012, 7 (09)
[6]   THE EFFECT OF CAPSULE COMPOSITION ON THE BIOCOMPATIBILITY OF ALGINATE-POLY-L-LYSINE CAPSULES [J].
CLAYTON, HA ;
LONDON, NJM ;
COLLOBY, PS ;
BELL, PRF ;
JAMES, RFL .
JOURNAL OF MICROENCAPSULATION, 1991, 8 (02) :221-233
[7]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[8]   The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells [J].
Ding, Ya-Hui ;
Fan, Hong-Xia ;
Long, Jing ;
Zhang, Quan ;
Chen, Yue .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (22) :6087-6092
[9]   IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer [J].
Greten, FR ;
Eckmann, L ;
Greten, TF ;
Park, JM ;
Li, ZW ;
Egan, LJ ;
Kagnoff, MF ;
Karin, M .
CELL, 2004, 118 (03) :285-296
[10]   Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β [J].
Hehner, SP ;
Heinrich, M ;
Bork, PM ;
Vogt, M ;
Ratter, F ;
Lehmann, V ;
Schulze-Osthoff, K ;
Dröge, W ;
Schmitz, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1288-1297